|
EP1992610A1
|
|
New route of synthesis
|
|
EP1992637A1
|
|
1-Aminocyclopentane-1,3,4- tricarboxylic acids derivatives
|
|
EP1961738A1
|
|
New compounds with antiglutamatergic properties and uses thereof
|
|
EP1798233A1
|
|
Pyrrolo[1,2-a]quinoxaline derivatives as Adenosine A3 receptor modulators and uses thereof
|
|
EP1777219A1
|
|
1,2-Substituted naphthalene derivatives with antiglutamatergic properties and uses thereof
|
|
EP1728511A1
|
|
New use of phenethicillin and salts thereof.
|
|
EP1604978A1
|
|
Trans pyrrolidinyl derivatives and their pharmaceutical uses
|
|
EP1604977A1
|
|
CIS pyrrolidinyl derivatives and their uses
|
|
EP1462103A1
|
|
NO donors, combination products and uses as modulators of neurotransmitter release
|
|
WO2004085395A1
|
|
Melatonin derivatives and their use for treating neurological dysfunctions
|
|
WO2004085392A1
|
|
Melatonin derivatives and their use for treating neurological dysfunctions
|
|
EP1371366A1
|
|
Methods for the prevention and/or the treatment of neurological disorders
|
|
AU2003236668A1
|
|
Methods for the prevention and/or the treatment of neurological disorders
|
|
US2004014648A1
|
|
Methods for the prevention and/or the treatment of neurological disorders
|
